Akili Has Big Pharma Buy-In For Cognitive Disorder Video Games

Alkili Interactive Labs, which is developing a video game to treat cognitive disorders, recently raised $30.5 million from PureTech, JAZZ Venture Partners and others

More from Archive

More from Medtech Insight